• Explore /
  • Poster
  • / Evolution of the functionality of microbial communities in patients with metastatic renal cell carcinoma (mRCC) receiving cabozantinib (cabo)/nivolumab (nivo) with or without CBM588: A randomized clinical trial.

Evolution of the functionality of microbial communities in patients with metastatic renal cell carcinoma (mRCC) receiving cabozantinib (cabo)/nivolumab (nivo) with or without CBM588: A randomized clinical trial.

Abstract Poster

Authors

Hedyeh Ebrahimi

Hedyeh Ebrahimi

City of Hope Comprehensive Cancer Center, Duarte, CA

Hedyeh Ebrahimi , Luis A Meza , Keehoon Lee , Jasnoor Malhotra , Marice Alcantara , Zeynep Busra Zengin , Nazli Dizman , Joann Hsu , Marian Llamas-Quitiquit , Daniela V. Castro , Benjamin D. Mercier , Regina Barragan-Carrillo , Neal Shiv Chawla , Xiaochen Li , Sandy Liu , Alex Chehrazi-Raffle , Tanya B. Dorff , Paul Henry Frankel , Abhishek Tripathi , Sumanta Kumar Pal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT05122546

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 460)

DOI

10.1200/JCO.2024.42.4_suppl.460

Abstract #

460

Poster Bd #

K1

Abstract Disclosures

Similar Posters

First Author: Nazli Dizman

First Author: M. Y. Al-Marrawi

First Author: Nourhan El Ahmar

First Author: Jessica Heejin Yoo